Correlation Between Atara Biotherapeutics and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atara Biotherapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atara Biotherapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atara Biotherapeutics and TG Therapeutics, you can compare the effects of market volatilities on Atara Biotherapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atara Biotherapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atara Biotherapeutics and TG Therapeutics.

Diversification Opportunities for Atara Biotherapeutics and TG Therapeutics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Atara and TGTX is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Atara Biotherapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Atara Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atara Biotherapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Atara Biotherapeutics i.e., Atara Biotherapeutics and TG Therapeutics go up and down completely randomly.

Pair Corralation between Atara Biotherapeutics and TG Therapeutics

Given the investment horizon of 90 days Atara Biotherapeutics is expected to under-perform the TG Therapeutics. In addition to that, Atara Biotherapeutics is 1.45 times more volatile than TG Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  816.00  in TG Therapeutics on August 26, 2024 and sell it today you would earn a total of  2,691  from holding TG Therapeutics or generate 329.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Atara Biotherapeutics  vs.  TG Therapeutics

 Performance 
       Timeline  
Atara Biotherapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Atara Biotherapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Atara Biotherapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
TG Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Atara Biotherapeutics and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atara Biotherapeutics and TG Therapeutics

The main advantage of trading using opposite Atara Biotherapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atara Biotherapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Atara Biotherapeutics and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data